National-, institutional-, and individual-level determinants of dental research excellence: an analysis of Stanford-Elsevier lists of the top 2% scholars worldwide (2017-2023)
Abstract
Background: Research excellence, distinct from productivity, is a key criterion in science policy and institutional evaluation. This study examined global distribution and determinants of dental research excellence using the Stanford-Elsevier Lists (SEL) of the top 2% most-cited scientists.
Methods: A bibliometric analysis was conducted using SEL datasets from 2017 to 2023. The analysis followed an ecological model consisting of three layers of independent variables: national-level indicators (macroeconomic metrics, oral disease burden, and development indices), institutional rankings, and individual-level variables (gender and academic age) were analysed. Descriptive statistics, multivariable regressions, and mixed-effects models were applied.
Results: The analysis demonstrated a markedly uneven global distribution of excellent dental scholars (EDS), with 96.1% and 88.9% of career-long and single-year EDS, respectively, based in high-income countries. English-speaking countries dominated, reflecting historical and linguistic biases. Institutional elitism was apparent, with 20 universities accounting for nearly one-fifth of all EDS worldwide. Gender disparities persisted, with women comprising only 14.8% (career-long) and 18.1% (single-year). Academic age consistently predicted scholarly metrics more strongly than gender. EDS numbers correlated positively with macroeconomic indicators, particularly R&D investment, while oral disease burden was negatively correlated.…
How strong is the evidence?
Evidence Hub reads this as a systematic review. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid.
Read the paper
Related studies
- The Matrisome: In Silico Definition and In Vivo Characterization by Proteomics of Normal and Tumor Extracellular Matrices
- The Escherichia coli MG1655 in silico metabolic genotype: Its definition, characteristics, and capabilities
- In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling
- In silico prediction of splice-altering single nucleotide variants in the human genome
- In silico clinical trials: how computer simulation will transform the biomedical industry
- In silico optimization of a guava antimicrobial peptide enables combinatorial exploration for peptide design
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.